IL-10 R alpha

IL-10 R alpha

IL-10 R alpha Molekülinformation

Molecule Name
Interleukin 10 receptor
Molekülalias
Interleukin-10 receptor subunit alpha,IL-10 receptor subunit alpha,IL-10R subunit alpha,IL-10RA,CDw210a,Interleukin-10 receptor subunit 1,IL-10R subunit 1,IL-10R1,CD210,IL10RA,IL10R
Drug Development Progress
Anzahl der klinischen Arzneimittel9
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical
Target-Alias
Receptors, Interleukin-10

IL-10 R alpha Produktliste

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
IAE-0972IAE-0972Phase 3 ClinicalSunHo (China) BioPharmaceutical Co Ltd
Carcinoma, Basosquamous; Carcinoma, Hepatocellular; Colorectal Neoplasms; Nasopharyngeal Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck
Details
Recombinant anti-human EGFR antibody/IL-10 bispecific Fc fusion protein(Dingfu Biotarget)CmAb-(IL10)2; DF203; DF-203Phase 2 ClinicalDingfu Biotarget Co Ltd
Ascites; Pleural Effusion, Malignant; Solid tumours
Details
AG-019AG-019Phase 2 ClinicalPrecigen Actobio Inc
Diabetes Mellitus, Type 1
Details
Meta 10C-IL-10 TILsMeta10-TIL; Meta 10C-IL-10 TILsPhase 2 ClinicalLeman Biotech Co Ltd
Neoplasms; Solid tumours
Details
IBB-0979IBB0979; IBB-0979Phase 2 ClinicalSunHo (China) BioPharmaceutical Co Ltd
Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Neoplasms; Peritoneal Neoplasms; Small Cell Lung Carcinoma; Solid tumours
Details
VimekofuspAMT-101 (Applied Molecular Transport)Phase 2 ClinicalApplied Molecular Transport
Colitis, Ulcerative
Details
F8-IL10F8-IL10; PF-06687234Phase 2 ClinicalPhilogen Spa
Arthritis, Rheumatoid; Colitis, Ulcerative; Inflammatory Bowel Diseases
Details
PEG-ilodecakinAM-0010Phase 1 ClinicalArmo Biosciences, Merck Sharp & Dohme Corp
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Granulomatosis with Polyangiitis; Melanoma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Solid tumours; Vasculitis
Details
Diakine-DK2 10 (EGFR)DK210; DK-2-10Phase 1 ClinicalDeka Biosciences Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Genital Neoplasms, Female; Head and Neck Neoplasms; Kidney Neoplasms; Neoplasms; Pancreatic Neoplasms; Skin Neoplasms; Solid tumours
Details